Dozens of congressional lawmakers are urging the Trump administration to force Eli Lilly to reinstate mandated price breaks ...

Colorado Democratic Rep. Diana DeGette, who lost her primary, was knowledgeable about biopharma, if not always a friend to ...

Bluebird Bio was a dark biotech morality tale when David Meek bought it. He says the new company, Genetix, is already making ...

CDC leadership continues to try manufacture a scientific debate on vaccines where none exists, writes Ben Lopman.

Reducing Medicare payments for 340B drugs is the latest proposal focused on the hotly debated drug discount program.

Elevance Health has sued the U.S. government, alleging that federal efforts to recalculate its Medicare Advantage quality ...

A federal judge blocked a Colorado state panel from placing a cap on the price of Enbrel, a blockbuster drug sold by Amgen ...

This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to ...

Companies are being too conservative in how they interpret FDA's AI guidance, but the agency can do more to help, too, Tala ...

Biotech's bull market, Vertex's gene therapy expansion, and more news from The Readout ...

A U.S. Centers for Medicare & Medicaid Services 18-month ​trial program will offer for the first time Novo Nordisk’s Wegovy ...

The presidential fitness test is back, surprising new data on the health risks of obesity, and more Morning Rounds news ...